Sun Pharma shares surge over 5% on $11.75-billion Organon deal
Summary
Sun Pharma shares rise over 5% after announcing an $11.75 billion acquisition of Organon, boosting investor confidence.
Description
Sun Pharma shares rise over 5% after announcing an $11.75 billion acquisition of Organon, boosting investor confidence.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source